Overview of the Interaction between Warfarin and Korean Herbal Medicine
![]() |
Lee, In
(Dept. of Korean Medicine, School of Korean Medicine, Pu-San National University)
Park, Sang-Moo (Dept. of Internal Medicine, College of Oriental Medicine, Won-Kwang University) Park, Seung-Chan (Dept. of Korean Medical Science, School of Korean Medicine, Pu-San National University) Kim, Do-Hyung (Dept. of Korean Medical Science, School of Korean Medicine, Pu-San National University) Cho, Min-Kyoung (Dept. of Internal Medicine, Korean Medicine Hospital of Pu-San National University) Han, Chang-Woo (Dept. of Korean Medicine, School of Korean Medicine, Pu-San National University) Kwon, Jeong-Nam (Dept. of Korean Medicine, School of Korean Medicine, Pu-San National University) Hong, Jin-Woo (Dept. of Korean Medicine, School of Korean Medicine, Pu-San National University) |
1 | Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence -Based Clinical Practice Guidelines(8th Edition). Chest 2008;133(6 Suppl):160S-98S. DOI |
2 | Brunton LL, Parker KL, Blumenthal DK, Buxton ILO. Goodman & Gilman's Manual of Pharmacology and Therapeutics. 1st edition. McGraw-Hill; 2008, p. 76. |
3 | Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008;152(3) :416-21. DOI ScienceOn |
4 | Nutescu EA, Shapiro NL, Ibrahim S, West P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf 2006;5(3):433-51. DOI ScienceOn |
5 | Hines LE, Ceron-Cabrera D, Romero K, Anthony M, Woosley RL, Armstrong EP, et al. Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. Clin Ther 2011;33(1):36-45. DOI ScienceOn |
6 | Wittkowsky AK. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis 2008;25(1) :72-7. DOI ScienceOn |
7 | Leung VW, Shalansky SJ, Lo MK, Jadusingh EA. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin. Ann Pharmacother 2009; 43(5):875-81. DOI ScienceOn |
8 | Lo AC, Chan K, Yeung JH, Woo KS. The effects of Danshen(Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats. Eur J Drug Metab Pharmacokinet 1992;17(4):257-62. DOI ScienceOn |
9 | Tam LS, Chan TYK, Leung WK, Critchley JAJH. Warfarin interactions with Chinese traditional medicines: Danshen and methyl salicylate medicated oil. Austr N Z J Med 1995;25(3):258. DOI ScienceOn |
10 | Chan TYK. Drug interactions as a cause of overanticoagulat in and bleedings in Chinese patients receiving warfarin. Int J Clin Pharmacol Ther 1998;36(7):403-5. |
11 | Yu CM, Chan JCN, Sanderson JE. Chinese herbs and warfarin potentiation by 'Danshen'. J Intern Med 1997;241(4):337-9. DOI ScienceOn |
12 | Izzat MB. A taste of Chinese medicine. Ann Thorac Surg 1998;66(3):941-2. DOI ScienceOn |
13 | 顔靑, 蔣錦琪. 丹參片對華法令抗凝作用影響. Chinese Traditional Patent Medicine 2008;30(1):19-21. |
14 | Page RL, Lawrence JD. Potentiation of warfarin by Dong Quai. Pharmacotherapy 1999;19(7) :870-6. DOI ScienceOn |
15 | Ellis GR, Stephens MR. Minerva. Br Med J 1999;319:650. DOI ScienceOn |
16 | Lo ACT, Chan K, Yeung JHK, Woo KS. Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. Eur J Drug Metab Pharmacokinet 1995;20(1):55-60. DOI ScienceOn |
17 | Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54(6):692-3. |
18 | Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med 2004;141(1):23-7. DOI ScienceOn |
19 | Jin YR, Yu JY, Lee JJ, You SH, Chung JH, Noh JY, et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 2007;100(3):170-5. DOI ScienceOn |
20 | Zhu M, Chan KW, Ng LS, Chang Q, Chang S, Li RC. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51(2) :175-80. DOI ScienceOn |
21 | Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008;14(6):715-21. DOI ScienceOn |
22 | Lee YH, Lee BK, Choi YJ, Yoon IK, Chang BC, Gwak HS. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int J Cardiol 2010;145(2) :275-6. DOI ScienceOn |
23 | Potterat O. Goji(Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Med 2010;76(1):7-19. DOI ScienceOn |
24 | Leung H, Hung A, Hui ACF, Chan TYK. Warfarin overdose due to the possible effects of Lycium barbarum L. Food Chem Toxicol 2008;46(5):1860-2. DOI ScienceOn |
25 | Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurol 1996;46(6):1775-6. DOI ScienceOn |
26 | Mathews MK. Association of ginkgo biloba with intracerebral haemorrhage. Neurol 1998;50(6) :1933-4. DOI |
27 | Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, longterm warfarin treated outpatients. A randomised, double blind, placebo -crossover trial. Thromb Haemost 2002;87(6) :1075-6. DOI |
28 | Jiang X, Williams KM, Liauw WS, Ammit AJ, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59(4):425-32. DOI ScienceOn |
29 | Kassebaum PJ, Shaw DL, Tomich DJ. Possible warfarin interaction with menthol cough drops. Ann Pharmacother 2005;39(2):365-7. DOI ScienceOn |
30 | Coderre K, Faria C, Dyer E. Probable warfarin interaction with menthol cough drops. Pharmacotherapy 2010;30(1):110. DOI ScienceOn |
31 | Lambert JP, Cormier J. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy 2001;21(4):509-12. DOI ScienceOn |
32 | Su Q, Li Y. Interaction between warfarin and the herbal product Shengmai-yin: a case report of intracerebral hematoma. Yonsei Med J 2010; 51(5):793-6. DOI ScienceOn |
33 | 竹田茂文, 疋田典子, 富樫裕二, 八田明, 竹田茂 文, 遠藤徹, et al. 數種漢方藥のワルファリンの 抗凝固作用に及ぼす影響. 和漢医藥學會大會要旨集 1996;13:87. |
34 | 間瀨 明人, 新井 一郞, 山本 雅浩, 石毛 敦, 前 村 俊一, 佐々木 博. ワルファリンと數種漢方藥 の倂用による血液凝固系に及ぼす影響. 和漢医藥 學會大會要旨集 1999;16:147. |
35 | Makino T, Wakushima H, Okamoto T, Okukubo Y, Deguchi Y, Kano Y. Pharmacokinetic interactions between warfarin and kangen-karyu, a Chinese traditional herbal medicine, and their synergistic action. J Ethnopharmacol 2002; 82(1):35-40. DOI ScienceOn |
36 | Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, et al.. Traditional Chinese Medicines Wu Wei Zi(Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) Activate Pregnane X Receptor and Increase Warfarin Clearance in Rats. J Pharmcol Exp Ther 2006; 316(3):1369-77. |
37 | Su Q, Li Y. Interaction between warfarin and the herbal product Shengmai-yin: a case report of intracerebral hematoma. Yonsei Med J 2010;51(5):793-6. DOI ScienceOn |
38 | Endo M, Hayasaki T, Oikawa T, Akahoshi T, Hanawa T. A case in which Kampo medicine affected warfarin control. J Trad Med 2008; 25(4):122-4. |
39 | Guyton AC, Hall JE. Textbook of Medical Physiology. 11th Edition. Philadelphia: Elsevier Inc.; 2006, p. 457-68. |
40 | Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 2005;45(2):127-32. DOI ScienceOn |
41 | 이상헌, 김영석, 강철호, 송문구, 두호경, 안세영, 등. 뇌경색 입원환자대상으로 한약과 Warfarin 의 복합 투여시 미치는 Prothrombin Time(INR) 의 변화에 대한 후향적 단면연구. 대한한방내과학회지 2007;28(3):464-72. |
42 | Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al.. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study(ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348(9025):423-8. DOI ScienceOn |
43 | Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998;279(9):657-62. DOI ScienceOn |
44 | 김은주, 이상호, 김이동, 윤상필, 이준우, 홍진우, 등. 뇌경색 환자의 Warfarin(Coumadin, Warfar) 복용 시 한약물이 INR에 미치는 영향. 대한한의학회지 2004;25(2):165-72. |
45 | 권승원, 박주영, 변형식, 윤승규, 서유리, 정우상, 등. Warfarin 복용시 인삼이 포함된 한약처방이 PT INR에 미치는 영향. 대한한방내과학회지 2010;31(3):675-87. |
46 | 권동현, 김호준, 이명종, 송미영. 한약과 와파린 병용의 상호작용과 안전성에 대한 연구.한방재활의학과학회지 2010;20(2):175-81. |
47 | 조우근, 권영주, 양나래, 김미경, 한창호. 와파린과 상호작용한 형방사백산 투약 2례. 한방내과학회 학술대회 논문집 2011;32(spr):277-82. |
48 | Wu WW, Yeung JH. Inhibition of warfarin hydroxylation by major tanshinones of Danshen(Salvia miltiorrhiza) in the rat in vitro and in vivo. Phytomedicine 2010;17(3-4) :219-26. DOI ScienceOn |
49 | Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52(5):587-95. DOI ScienceOn |
50 | Lam AY, Elmer GW, Mohutsky MA. Possible interaction between warfarin and Lycium barbarum L. Ann Pharmacother 2001;35(10) :1199-201. DOI |
51 | Bone KM. Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence?. Mol Nutr Food Res 2008;52(7):764-71. DOI ScienceOn |
![]() |